Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2020 Results - Earnings Call Transcript

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET

Company Participants

Trevin Rard – Investor Relations
Mike Hunkapiller – Chief Executive Officer
Susan Barnes – Chief Financial Officer
Ben Gong – Vice President of Finance and Treasurer

Conference Call Participants

Subbu Nambi – Cowen
Rachel Vatnsdal – Piper Sandler
Kyle Mikson – Cantor Fitzgerald

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Pacific Biosciences of California, Inc. First Quarter 2020 Earnings Conference Call. [Operator Instructions]

I would now like to hand the conference over to your first speaker today, Ms. Trevin Rard. Ma’am, please go ahead.

Trevin Rard

Good afternoon, and welcome to the Pacific Biosciences first quarter 2020 conference call. We hope that you are keeping well during this time. We’re hosting our call from a number of different locations today, so please bear with us if there are any technical challenges or pauses.

Earlier today, we issued a press release outlining the financial results we will be discussing on today’s call, a copy of which is available on the Investors section of our website at www.pacb.com or, alternatively, as furnished on the Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. With me today are Mike Hunkapiller, our Chief Executive Officer; Susan Barnes, our Chief Financial Officer; and Ben Gong, our Vice President of Finance and Treasurer.

Before we begin, I would like to remind you that on today’s call, we may be making forward-looking statements, including plans and expectations relating to our financial projections, products and other future events, such as the impact of COVID-19 pandemic on our business partners, customers and employees and the use of our products in COVID-19 research.

You should not place undue reliance on forward-looking statements